The European Medicines Agency (“EMA”) and the EU network of Health Technology Assessment (“HTA”) bodies are jointly reviewing a proposed framework for patient preference studies. The intention of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results